PMcardio receives FDA Breakthrough Device Designation — read the full story
Get access
Powerful Medical
•
10. January 2025
•
2 min to read
  • Case Report

The Crucial Role of Image Quality in AI-enabled ECG Digitization and Interpretation of Occlusion Myocardial Infarction

Link to Publication

Overview:

The effectiveness of AI-ECG tools depends on the quality of input data—poor ECG image quality can lead to critical misdiagnoses. This case shows how a low-quality scan triggered a false STEMI alert, later corrected with improved digitization. It underscores the importance of ensuring minimally acceptable image quality, as even advanced tools can’t fully correct severe distortions.

Published In: Journal of Electrocardiology

Date of Publication: January 10, 2025

Highlights

  • Acceptable digitization of ECG images requires a minimal quality of input
  • Contemporary digitization by the PMcardio digitization software can correct many, but not all, distortions and deletions
  • Proportionality between QRS and ST/T is crucial; truncation of any part of the QRS or ST/T distorts these proportions.


Authors: Robert Herman, MD, PhD; Stephen W. Smith, MD

Link to Publication
Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

All Publications
  • Study
  • Journal of Personalized Medicine
  • March 28, 2025

Artificial Intelligence Detection of Occlusive Myocardial Infarction from Electrocardiograms Interpreted as “Normal” by Conventional Algorithms

Conventional ECG algorithms, humanly programmed to detect abnormalities based on fiducial points, frequently miss critical patterns of STEMI. AI-driven deep neural network models like PMcardio AI ECG offer significant potential in identifying these dangerous false negatives, reducing the risk of false reassurance, and enhancing clinical decision-making.
  • Associated Research, Study
  • Annals of Emergency Medicine
  • January 17, 2025

ECG Patterns of Occlusion Myocardial Infarction: a Narrative Review

This comprehensive review highlights the limitations of the traditional STEMI/NSTEMI classification for heart attacks and advocates for a more precise approach to diagnosis and patient triage. Instead of relying solely on standard ECG criteria, this method focuses on ECG patterns that more accurately reflect the severity of underlying coronary vessel disease. By identifying high-risk ECG changes beyond current STEMI guidelines, clinicians can detect heart attacks earlier, initiate treatment faster, and ultimately improve patient outcomes.
More articles

Join over 100,000 healthcare professionals who are already taking advantage of AI

Register now

Ready to get started?

Get access

Powerful Medical is redefining the landscape of medical diagnostics with its AI-driven solutions. The company’s certified PMcardio platform revolutionizes the way cardiovascular diseases are detected, offering rapid and accurate diagnostics that pave the way for timely and effective treatment.

Products

Company

Resources

Legal

Envelope Linkedin-in Instagram Facebook-f

© Powerful Medical 2025

Privacy

&

Cookies

Legal

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region.

Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region. Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Sign up